脂蛋白(a)与心血管疾病
约五分之一人群因脂蛋白(a)升高而处于动脉粥样硬化性心血管疾病和主动脉瓣狭窄高风险。脂蛋白(a)浓度90%以上由遗传决定,绝经后女性比男性高17%。目前无获批降低脂蛋白(a)的药物,至少五种在研药物可降低65-98%,其中三种正在大型心血管终点试验中测试。
要点
- 脂蛋白(a)浓度90%以上由遗传决定,绝经后女性比男性高17%。
- 心血管风险较高者应一生中检测一次脂蛋白(a)浓度。
- 目前无获批降低脂蛋白(a)的药物,至少五种在研药物可降低65-98%。
核心结论
- 约五分之一人群因脂蛋白(a)升高而处于动脉粥样硬化性心血管疾病和主动脉瓣狭窄高风险。
- 目前无获批降低脂蛋白(a)浓度的药物,至少五种在研药物可降低65-98%,其中三种正在大型心血管终点试验中测试。
研究设计与样本
- 本文为综述,涵盖历史视角、生理与病理生理、因果关系的遗传学证据、流行病学、在家族性高胆固醇血症和糖尿病中的作用、管理、筛查、诊断、测量、预防及未来降低脂蛋白(a)的药物。
主要发现
- 脂蛋白(a)浓度在东亚洲、欧洲和东南亚人群中最低,在南亚、中东和拉丁美洲人群中居中,在非洲人群中最高。
- 脂蛋白(a)浓度90%以上由遗传决定,绝经后女性比男性高17%。
- 至少五种在研药物降低脂蛋白(a)浓度65-98%,其中三种正在大型心血管终点试验中测试。
关键数值与推荐
- 心血管风险较高的个体应一生中检测一次脂蛋白(a)浓度。
临床怎么用
- 心血管风险较高的个体应一生中检测一次脂蛋白(a)浓度,以告知高浓度者坚持健康生活方式并接受药物降低其他心血管危险因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One in five people are at high risk for atherosclerotic cardiovascular disease and aortic valve stenosis due to high lipoprotein(a). Lipoprotein(a) concentrations are lowest in people from east Asia, Europe, and southeast Asia, intermediate in people from south Asia, the Middle East, and Latin America, and highest in people from Africa. Concentrations are more than 90% genetically determined and 17% higher in post-menopausal women than in men. Individuals at a higher cardiovascular risk should have lipoprotein(a) concentrations measured once in their lifetime to inform those with high concentrations to adhere to a healthy lifestyle and receive medication to lower other cardiovascular risk factors. With no approved drugs to lower lipoprotein(a) concentrations, it is promising that at least five drugs in development lower concentrations by 65-98%, with three currently being tested in large cardiovascular endpoint trials. This Review covers historical perspectives, physiology and pathophysiology, genetic evidence of causality, epidemiology, role in familial hypercholesterolaemia and diabetes, management, screening, diagnosis, measurement, prevention, and future lipoprotein(a)-lowering drugs.
引用
- Nordestgaard BG, Langsted A. Lipoprotein(a) and cardiovascular disease. Lancet. 2024. PMID: 39278229. doi:10.1016/S0140-6736(24)01308-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。